Biomedical Engineering Design and the Promotion of High Value Relationships with Clinical Medicine Robert Hitchcock.
Download ReportTranscript Biomedical Engineering Design and the Promotion of High Value Relationships with Clinical Medicine Robert Hitchcock.
Biomedical Engineering Design and the Promotion of High Value Relationships with Clinical Medicine Robert Hitchcock Background A highly regulated industry Collaborative development environment Utah BioDesign University resources and vision Course Highlights Projects are initiated by clinicians Students interact with clinicians Focus on FDA Quality System Regulation – Design Controls Projects required to follow Standard Operating Procedures Regulatory Environment USPTO FDA CSA ASTM IEC EC JCAHO GHTF ISTA ISO Why Design Control? Systematic • Allows organizations to develop design processes that meet their needs. Team based • Multidisciplinary teams are empowered to make decisions. Customer focused • Requirements play a key role in driving specifications and validation. Robust • Verification and validation ensure a higher quality design. Required by law Design Control SOPs Approach used by all medical device and pharmaceutical companies Interprets FDA QSR for design course Creates common ground for students Provides consistent guidelines for assessment “Audit" students as part of their assessment Design Control SOPs Document Name Doc. # Description Regulatory Fulfillment Design Control Policy DC 04 01 Outline the procedures to follow to develop new, or modify existing products. 21 CFR 820.30 (a) Design Input – Marketing Brief, Product Specification Considerations DC 04 04 Provides a procedure to develop the items that must be considered and documented in the design input phase of device development. 21 CFR 820.30 (c) Design and Development Planning DC 04 12 To indicate the factors that may be considered in the generation of a design and development plan (the Plan) for a new product, product improvement, or product modification, or components of products 21 CFR 820.30 (b) Design Changes DC 04 20 To indicate the process to be followed when changing, or making additions to, approved documents that are included as part of Design History Files. 21 CFR 820.30 (i) Design Review DC 04 16 to indicate the process to be followed to conduct Design Reviews. 21 CFR 820.30 (i) Design Validation DC 04 28 To indicate the general process to follow and the documentation required to establish a Design Validation Plan and perform Design Validations of new and revised designs (products). 21 CFR 820.30 (g) Design Verification DC 04 24 To indicate the general process to follow and the documentation required to establish a Design Verification Plan and perform Design Verifications of new and revised designs (products). 21 CFR 820.30 (f) Device Master Record DC 04 16 to indicate the contents of a Device Master Record (DMR). 21 CFR 820.121 Course Timeline – Spring / Fall Projects Bone marrow aspiration device Heart patch for stem cell delivery Third heart sound monitor Optically guided feeding tube Fiber optic respirometer